These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Structure of the Recombinant Almonacid-Mendoza HL; Humbert MV; Dijokaite A; Cleary DW; Soo Y; Hung MC; Orr CM; Machelett MM; Tews I; Christodoulides M mSphere; 2018 Oct; 3(5):. PubMed ID: 30305317 [No Abstract] [Full Text] [Related]
10. Experimental vaccine induces Th1-driven immune responses and resistance to Neisseria gonorrhoeae infection in a murine model. Liu Y; Hammer LA; Liu W; Hobbs MM; Zielke RA; Sikora AE; Jerse AE; Egilmez NK; Russell MW Mucosal Immunol; 2017 Nov; 10(6):1594-1608. PubMed ID: 28272393 [TBL] [Abstract][Full Text] [Related]
11. Diversion of the immune response to Neisseria gonorrhoeae from Th17 to Th1/Th2 by treatment with anti-transforming growth factor β antibody generates immunological memory and protective immunity. Liu Y; Russell MW mBio; 2011; 2(3):e00095-11. PubMed ID: 21610119 [TBL] [Abstract][Full Text] [Related]
12. VA-MENGOC-BC Vaccination Induces Serum and Mucosal Anti Neisseria gonorrhoeae Immune Responses and Reduces the Incidence of Gonorrhea. Reyes Díaz LM; Lastre González MSJB; Cuello M; Sierra-González VG; Ramos Pupo R; Lantero MI; Harandi AM; Black S; Pérez O Pediatr Infect Dis J; 2021 Apr; 40(4):375-381. PubMed ID: 33591079 [TBL] [Abstract][Full Text] [Related]
13. The Serogroup B Meningococcal Vaccine Bexsero Elicits Antibodies to Neisseria gonorrhoeae. Semchenko EA; Tan A; Borrow R; Seib KL Clin Infect Dis; 2019 Sep; 69(7):1101-1111. PubMed ID: 30551148 [TBL] [Abstract][Full Text] [Related]